Retrospective review of oral and topical minoxidil for cancer treatment-induced hair loss

Arch Dermatol Res. 2023 Nov;315(9):2613-2615. doi: 10.1007/s00403-023-02660-z. Epub 2023 Jul 8.

Authors

Abena Minta¹, Candice Park¹, Lucy Rose¹, Stephanie Trovato¹, Brittany Dulmage²

Affiliations

¹ Department of Dermatology, The Ohio State University Wexner Medical Center, 540 Officenter Place, Suite 240, Gahanna, OH, 43230, USA.
² Department of Dermatology, The Ohio State University Wexner Medical Center, 540 Officenter Place, Suite 240, Gahanna, OH, 43230, USA. Brittany.dulmage@osumc.edu.

PMID: 37421421
DOI: 10.1007/s00403-023-02660-z

No abstract available

Keywords: Alopecia; Minoxidil; Oncodermatology; Oncology; To the editor.

MeSH terms

Administration, Topical
Alopecia / chemically induced
Alopecia / drug therapy
Hair
Humans
Minoxidil* / adverse effects
Neoplasms* / drug therapy
Retrospective Studies
Treatment Outcome

Substances

Minoxidil